BR100 Increased By (1.02%)
BR30 Increased By (1.71%)
KSE100 Increased By (0.58%)
KSE30 Increased By (0.65%)
BECO 6.03 Increased By ▲ 0.26 (4.51%)
BML 52.61 Decreased By ▼ -0.39 (-0.74%)
BOP 34.23 Increased By ▲ 0.24 (0.71%)
CNERGY 8.16 Increased By ▲ 0.05 (0.62%)
DCL 12.23 Increased By ▲ 0.03 (0.25%)
FCCL 53.80 Increased By ▲ 0.97 (1.84%)
FCSC 5.24 Increased By ▲ 0.17 (3.35%)
FFL 18.03 Increased By ▲ 0.08 (0.45%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 11.00 Increased By ▲ 0.12 (1.1%)
KEL 8.07 Increased By ▲ 0.05 (0.62%)
KOSM 5.39 Decreased By ▼ -0.13 (-2.36%)
MLCF 87.90 Increased By ▲ 1.39 (1.61%)
NBP 186.60 Increased By ▲ 1.44 (0.78%)
PACE 10.75 Increased By ▲ 0.17 (1.61%)
PAEL 39.95 Increased By ▲ 0.53 (1.34%)
PIAHCLA 26.19 Decreased By ▼ -0.03 (-0.11%)
PIBTL 17.32 Increased By ▲ 0.65 (3.9%)
PPL 233.49 Increased By ▲ 5.31 (2.33%)
PRL 34.98 Increased By ▲ 0.30 (0.87%)
PTC 67.71 Increased By ▲ 2.38 (3.64%)
SEARL 90.90 Increased By ▲ 0.77 (0.85%)
SSGC 27.20 Increased By ▲ 0.60 (2.26%)
TELE 8.57 Increased By ▲ 0.29 (3.5%)
THCCL 60.85 Increased By ▲ 2.35 (4.02%)
TPLP 8.78 Increased By ▲ 0.56 (6.81%)
TREET 24.65 Increased By ▲ 0.12 (0.49%)
TRG 71.50 Increased By ▲ 1.79 (2.57%)
WAVES 10.01 Increased By ▲ 0.07 (0.7%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)

KARACHI: Interactive Research and Development (IRD) has partnered with JS Global Capital Limited and Biologica to provide free COVID-19 testing services to JS Global’s staff.

Funded by the Foundation for Innovative New Diagnostics (FIND), the testing services will be provided through WellCheck, IRD’s global corporate health and wellness program.

The signing ceremony was held at JS Group’s Head Office in Karachi and was attended by Kamran Nasir, CEO and Imtiaz Gadar, Deputy CEO, JS Global; Faisal Ismail, CEO, Biologica and Capt (R) Muhammad Habib Khan, COO, IRD Pakistan along with other senior officials from the organizations.

Speaking on the occasion, Kamran Nasir emphasized JS Global’s commitment to upholding employee safety and prioritizing employee health.

Capt (R) Muhammad Habib Khan, COO IRD Pakistan, highlighted, “IRD has expanded on its learnings from different programs like mental health and COVID-19 response efforts to identify a niche for provision of holistic health care services for its partnering organizations, under its WellCheck program.

This program offers health screenings, diagnostics, disease condition management, mental health support, free COVID-19 testing and linkage to care. IRD is aiding partners such as JS Global in creating a healthy and safe work environment for their employees.”

Faisal Ismail, Biologica CEO, also spoke on the importance of increasing access to health services for frontline workers and stands committed to ensure high quality adequate supply of Rapid Antigen Test Kits and other IVDs at affordable prices in Pakistan.

JS Global Capital Limited is one of Pakistan’s largest Broking and Investment Banking firms with a continued leadership position in the domestic capital markets.

IRD is a research and health delivery organization that creates novel health infrastructures by leveraging technology and developing capacity with community stakeholders. IRD provides quality health care services in areas of infectious diseases, non-communicable diseases, mental health, maternal and child health care across underprivileged communities in Pakistan and over 15 other countries.

Copyright Business Recorder, 2022

Comments

Comments are closed for this article.